Swiss medicines authority issues first approval for antimalarial drug for treatment of infants

Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of thousands of lives – nearly all in Africa – each year.



Source link